Sagimet Biosciences Balance Sheet (2023-2024) | SGMT

Balance Sheet Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024
Assets
Current Assets
Cash & Equivalents 18.51M101.84M75.14M176.78M95.96M77.01M
Short-term Investments 19.76M16.93M70.41M75.47M
Cash & Current Investments 18.51M101.84M94.90M193.71M166.37M152.49M
Current Deferred Tax Assets 2.64M0.32M0.31M
Prepaid Assets 2.85M0.97M1.75M0.79M0.38M4.70M
Current Assets 21.35M102.82M96.65M194.49M166.75M157.19M
Non-Current Assets
Long-Term Investments 22.12M17.47M
Non-Current Assets 0.14M0.11M0.07M0.04M22.27M17.59M
Assets 21.50M102.92M96.72M194.53M189.02M174.78M
Liabilities
Current Liabilities
Accounts Payables 2.72M1.70M0.19M0.53M1.99M1.15M
Payables 2.72M1.70M0.19M0.53M1.99M1.15M
Accumulated Expenses 2.42M3.24M5.40M3.95M3.58M2.82M
Other Accumulated Expenses 0.10M0.10M0.23M0.01M0.01M
Current Leases 0.14M0.10M0.07M0.03M0.15M0.12M
Total Current Liabilities 5.29M5.05M5.65M
Non-Current Liabilities
Preferred Stock Liabilities 214.62M
Other Non-Current Liabilities 0.01M0.00M
Total Non-Current Liabilities 5.29M5.05M
Total Liabilities 5.29M5.05M5.65M4.51M5.73M4.09M
Shareholder's Equity
Common Equity -198.41M97.88M91.06M190.02M183.29M170.68M
Shareholder's Equity -198.41M97.88M91.06M190.02M183.29M170.68M
Liabilities and Shareholders Equity 21.50M102.92M96.72M194.53M189.02M174.78M
Retained Earnings -235.24M-241.59M-249.74M-256.40M-264.50M-279.11M
Treasury Shares 1.13M1.13M1.13M0.84M